Filter
1803
Filtered Results: 1803
Text search:
pharmaceutical
needs
Featured
Recommendations
163
New Publications
506
Language
Document type
No document type
969
Studies & Reports
327
Guidelines
258
Manuals
89
Strategic & Response Plan
86
Fact sheets
23
Training Material
22
Situation Updates
14
Resource Platforms
5
Infographics
5
Brochures
3
Online Courses
2
Countries / Regions
India
79
Kenya
71
Ethiopia
69
Global
68
South Africa
50
Western and Central Europe
44
Nigeria
42
Uganda
40
Liberia
36
Sierra Leone
34
Namibia
25
Nepal
24
Zambia
24
Tanzania
24
Rwanda
24
Bangladesh
23
Malawi
23
Ukraine
23
Ghana
22
Africa
22
Syria
19
Eastern Europe
19
Zimbabwe
17
Philippines
17
Cambodia
16
Lesotho
15
South–East Asia Region
14
Latin America and the Carribbean
14
Indonesia
12
Myanmar / Burma
11
Eswatini/ Swaziland
10
West and Central Africa
9
South Sudan
8
Botswana
8
East and Southern Africa
8
Eastern Europe and Central Asia
8
Congo, Democratic Republic of
7
Cameroon
7
Germany
7
Asia
7
Venezuela
7
Senegal
6
Haiti
6
Guinea
5
Burkina Faso
5
Pakistan
5
Middle East and North Africa
5
Western Pacific Region
5
Papua New Guinea
4
Vietnam
4
Mali
3
USA
3
Jordan
3
Afghanistan
3
Lebanon
3
Egypt
3
Thailand
3
Mozambique
3
Brazil
3
North Macedonia
3
Albania
3
Laos
3
Russia
3
North America
3
United Kingdom
3
Iraq
2
China
2
Sudan
2
Benin
2
Central African Republic
2
Peru
2
Serbia
2
Yemen
2
Fiji
2
Southern Africa
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Chad
1
Malaysia
1
Ireland
1
El Salvador
1
Libya
1
Sri Lanka
1
Bhutan
1
Palestine
1
Armenia
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
749
Clinical Guidelines
117
Public Health
100
Key Resources
70
Women & Child Health
46
Pharmacy & Technologies
25
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
158
Pharmacy
154
COVID-19
136
Mental Health
107
HIV
100
TB
85
Rapid Response
56
NCDs
42
Planetary Health
40
Caregiver
39
NTDs
38
Global Health Education
35
Conflict
34
Ebola
30
Health Financing Toolbox
26
Disability
15
Refugee
14
Specific Hazards
12
Polio
11
Natural Hazards
9
Cholera
4
Zika
3
Social Ethics
3
Health Financing
2
South Sudan
1
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
Cholera is a diarrheal disease caused by the bacterium Vibrio cholera. The infection primarily spreads through contaminated water and food. Symptoms include the onset of acute diarrhea and/or vomiting, muscle cramps, and body weakness. If untreated, the infection can result in rapid dehydration and ...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination and eradication programmes;
• expand and implemen...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta...
World Health Organization. (2021). Minimum technical standards and recommendations for reproductive, maternal, newborn and child health care for emergency medical teams. World Health Organization.
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This paper has been prepared to inform discussion at the conference “Beating the DRUM - Domestic Resource Use and Mobilization for accelerating progress towards SDG3,”. Many countries face critical shortfalls in domestic resource use and mobilization (DRUM) for health, threatening to push health...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in the capacities of countries at all levels of develop...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
